ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

Report Criticizes NIH Grant Review

June 16, 1995

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

Patients Who Smoke In Treatment Do Worse Than Those Who Quit

March 25, 2011

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001